Delighted to announce that we have completed a successful pre-IND meeting with FDA on our oncology product SH105. The FDA’s prompt and definitive response confirms our clinical and regulatory strategy and aligns with our plan to accelerate the filling of our NDA. This positive outcome strengthens our efforts to bring SH105 to market benefiting women suffering […]
Shorla Pharma were delighted to recently attend ASCO’s annual meeting in Chicago and be present among healthcare professionals, patient advocates and scientists from around the world all of whom share the same goal: Improving the lives of patients with cancer.
Shorla were extremely honoured to accept the Network Ireland Tipperary, Businesswoman of the year award for Emerging New Business. Orlaith will go on to represent Shorla and Tipperary in the national finals in September. Congratulations to all the finalists and award winners.